There are three critical areas where companies most often go wrong: data preparation and training, choosing tools and specialists and timing and planning.
Imagine trying to design a key for a lock that is constantly changing its shape. That is the exact challenge we face in modern drug discovery when dealing with intrinsically disordered proteins.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results